Leadership Team

Over the last 20 years, Will has led health service, technology and finance companies, connecting key participants in the healthcare industry. As CEO and Director of OptimizeRx, he has continued to drive innovation in healthcare, and over the last several years, he has led the transformation of OptimizeRx into a leading digital health company that facilitates communication at the point-of-care for better health outcomes.

In 1999, Will co-founded and became CEO of MedPanel, a market intelligence and communication provider to the life sciences and financial industries. MedPanel was acquired in 2007 by Merriman Capital, a leading investment bank. At Merriman, he served as COO of investment banking and CEO of the firm’s Digital Capital Network. He launched pioneering digital compliance and transparency products and was part of the management team that raised more than $500 million in banking and M&A transactions.

Will earlier held a number of M&A and international business development roles at multinational companies involved in automotive, medical, precious metals and other industries.  

He currently serves as a faculty member for Massachusetts Institute of Technology’s linQ program, a collaborative initiative increasing the potential of innovative biomedical research to benefit society and the economy.

Will serves on board of The United Nations of Greater Boston, a non-profit focused on building a stronger network of global citizens in the Boston area. He also serves as a board member of Modular Medical, an early stage public medical device company. 

Will earned his Bachelor of Arts in International Studies and Spanish from Dickinson College, Pennsylvania. He is fluent in Spanish, married with three children and enjoys playing soccer.

Steve Silvestro brings more than 20 years’ experience in direct operations, sales, and partner network growth, to lead revenue activities and strengthen the go-to-market.

Steve is responsible for driving OptimizeRx's platform revenue growth including enterprise-level direct-to-patient and direct-to-provider product adoption to improve patient outcomes.

During his tenure at Decision Resources Group, he was an instrumental leader in the growth of the company from $30 million to $180 million in revenue. His customer-first philosophy is greatly aligned to our values at OptimizeRx.  

Steve previously served as vice president and general manager at CCH Tagetik, a division of Wolters Kluwer. Prior pharma leadership experience includes executive positions with Prognos, Decision Resources Group and D.M.S. Silvestro has extensive channel expertise in biopharma commercialization, global market access, market research, analytics, enterprise SaaS solutions and strategy.  

Silvestro received a master’s degree in Business Management from Harvard University. He also holds undergraduate degrees from Brigham Young University in both Business and Italian. He is fluent in English, Italian, Spanish and conversational in French. 

A seasoned leader with a passion for innovation in healthcare, Theresa brings over 20 years of experience driving commercial success. Her expertise spans healthcare data, analytics, technology, and consulting services.

In October 2023, she joined OptimizeRx as its Chief Commercial Officer following the Company’s acquisition of Healthy Offers, Inc. (“Medicx Health”), where she served as President. Previously, Theresa held Chief Commercial Officer positions at leading healthcare companies such as MediSpend and Prognos Health where she led product strategy, marketing, sales, and customer delivery. 

Her career includes notable roles at LexisNexis Healthcare, where she contributed to revenue growth and profitability. Additionally, she led the Life Sciences consulting group at Computer Sciences Corporation and held various positions at IQVIA and Pfizer.   

Theresa holds a Master of Business Administration in Healthcare Administration Management from Temple University. She completed her undergraduate studies at Ursinus College, earning a Bachelor of Science degree. 

Ed has over 30 years of diverse experience at organizations going through transformational changes, including international expansions, new product launches, financial/operational turnarounds, mergers & acquisitions, resource prioritization, strategy creation, and digital innovation. In his senior leadership roles, Ed has continually brought lasting positive culture changes and purpose to the organizations he serves.

Prior to joining OptimizeRx Ed served in a variety of leadership roles at Otsuka America Pharmaceuticals Inc.  His tenure with Otsuka began as a CFO leading the finance team on a transformative journey to help steer the organization through Abilify loss of exclusivity (LOE).  It culminated in an appointment as CFO/COO to lead a ~400 person, multi-functional team of professionals through product lifecycle management, new product launches, strategy development, alliance governance, M&A and COVID-19 response.  Over his tenure, the US organization evolved to be one of the best performing businesses for Otsuka globally and built best-in-class capabilities across a number of key enterprise functions through significant process optimization and automation initiatives.

Ed’s career has taken him across the globe, including foreign expat assignments in the Netherlands and Russia.  He has held positions of increasing responsibilities in finance and operations at Covance/LabCorp, Mylan, Organon/Schering-Plough, Sanofi-Aventis and Johnson & Johnson.

Outside of work, Ed serves as the Treasurer and Executive Committee member of the American Foundation of Suicide Prevention in NYC, and as a member of the Advisory Committee of the Arts Council of Princeton.

He received his Bachelor of Science in Finance from Towson University and his MBA from the University of Baltimore. He is also a Certified Public Accountant (inactive) in the State of New Jersey and a Certified Management Accountant. He is married with two adult children, and fluent in Russian.

Marion is a corporate lawyer with over 25 years of large firm and in-house experiences in a broad range of industries including life sciences, biotech, high tech, business consulting, professional services, banking and finance companies.  She is a critical thinker with strong global management, leadership, analytical, communication and problem-solving skills with emphasis on providing practical and proactive solutions to complex legal and business issues in both the domestic and international arenas.

Marion joined OptimizeRx as the Chief Compliance Officer and General Counsel in February 2021.  Marion oversees the Compliance/Corporate Governance, Legal/Contracts and Human Resources teams.  Her areas of expertise include corporate, mergers and acquisitions and securities; complex transactions and global commercial contracts; privacy and IT security compliance; technology and licensing; labor and employment; corporate policy development and training; and corporate governance and board relations. 

Prior to joining OptimizeRx, Marion worked in various leadership roles in both public and private companies.  She began her legal career in private practice at the Boston law firm of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC, where she advised public and private companies on corporate matters.

Marion received her J.D. from Northeastern University, her M.Phil from the University of Cambridge, and her B.A. from Columbia University.  Marion lives in Cambridge, Massachusetts, is married, has two adult children, and is fluent in Korean and proficient in Italian.

Dr. Doug Besch has nearly 20 years of experience in healthcare leadership. Throughout his career, Doug has demonstrated expertise in product strategy and innovation within the healthcare industry. 

Prior to his current role, he served as the Vice President of Market Access & Payer Solutions for Clarivate and Vice President of Payor Product & Innovation at Decision Resources Group. In these positions, he was instrumental in setting product vision and strategy, aligning cross-functional teams, and securing investments for strategic initiatives. 

Dr. Besch was a co-founder and the Chief Product Officer for Rx Savings Solution, a company that helps members and payers reduce prescription drug costs through a combination of clinical technology, transparency, member engagement, and concierge support.  His professional journey began as a pharmacist for the Walgreens Boots Alliance.  

Dr. Besch holds a Doctor of Pharmacy (PharmD) degree and a Master of Business Administration from Creighton University, complemented by a Bachelor of Science from Simpson College.

Brian McCarthy brings over two decades of experience in sales and marketing leadership within the technology sector to OptimizeRx. Throughout his career, Brian has held several high-impact leadership positions including Harris Computer, a Constellation Software Company, where he served as the Vice President of Sales & Marketing for Harris Affinity Decision Support, Harris Healthcare. In this role, he successfully established and led the sales and marketing organization for a newly acquired business unit, achieving strong growth milestones, including a 40% annual increase in US new bookings and a 20-fold improvement in funnel activity.

Prior to Harris Computer, Brian was the Senior Vice President of Sales for Wolters Kluwer's Tax & Accounting division in the Asia Pacific region, where he was instrumental in restructuring and scaling the sales function, leading to a significant revenue increase and enhanced customer engagement. His strategic leadership and operational excellence contributed to generating over $100 million in annual revenue across multiple countries.

Brian's career is marked by numerous accolades and achievements, including multiple Top Sales Producer and President’s Club recognitions. He has been a pivotal figure in driving three successful start-ups and supporting five corporate acquisitions, consistently surpassing growth targets with a year-on-year revenue improvement of over 50%.